Curis (CRIS)

• Market cap: $23.6M
• 1 day: -4.12%
• 5 days: -6.06%
• 1 month: -13.35%
• 3 months: -29.55%
• 6 months: -43.41%
• Year to date: -34.20%
• 1 year: -73.04%
• 5 years: -86.71%
• 10 years: -99.10%
• Sector: Healthcare
• Industry: Biological Products, Except Diagnostic Substances

About: Curis Inc is a biotechnology company that develops and commercializes innovative drugs and therapies in the immuno-oncology and precision oncology therapeutic areas. The company targets solid tumors, diffuse large B-cell lymphoma, advanced solid tumors or lymphomas, hematological cancers, and others. Its pipeline products include Fimepinostat, CA-170, CA-4948, CA-327, and Erivedge.

Employees: 49

Fund manager confidence

Based on 2024 Q4 regulatory filings by fund managers ($100M+ AUM)

900% more first-time investments, than exits

New positions opened: 10 | Existing positions closed: 1

367% more repeat investments, than reductions

Existing positions increased: 14 | Existing positions reduced: 3

29% more funds holding

Funds holding: 31 [Q3] → 40 (+9) [Q4]

4.21% more ownership

Funds ownership: 33.74% [Q3] → 37.95% (+4.21%) [Q4]

0% more funds holding in top 10

Funds holding in top 10: 1 [Q3] → 1 (+0) [Q4]

10% less capital invested

Capital invested by funds: $10.9M [Q3] → $9.84M (-$1.04M) [Q4]